Inactivated Vaccine for Swine Mycoplasma Pneumonia and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Inactivated Vaccine for Swine Mycoplasma Pneumonia Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Overall Market Size
2.1 Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Market Size: 2023 VS 2030
2.2 Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales: 2019-2030
3 Company Landscape
3.1 Top Inactivated Vaccine for Swine Mycoplasma Pneumonia Players in Global Market
3.2 Top Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Companies Ranked by Revenue
3.3 Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue by Companies
3.4 Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales by Companies
3.5 Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Inactivated Vaccine for Swine Mycoplasma Pneumonia Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Inactivated Vaccine for Swine Mycoplasma Pneumonia Product Type
3.8 Tier 1, Tier 2 and Tier 3 Inactivated Vaccine for Swine Mycoplasma Pneumonia Players in Global Market
3.8.1 List of Global Tier 1 Inactivated Vaccine for Swine Mycoplasma Pneumonia Companies
3.8.2 List of Global Tier 2 and Tier 3 Inactivated Vaccine for Swine Mycoplasma Pneumonia Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Market Size Markets, 2023 & 2030
4.1.2 Single Vaccine
4.1.3 Dual Vaccine
4.2 By Type - Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue & Forecasts
4.2.1 By Type - Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue, 2019-2024
4.2.2 By Type - Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue, 2025-2030
4.2.3 By Type - Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue Market Share, 2019-2030
4.3 By Type - Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales & Forecasts
4.3.1 By Type - Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales, 2019-2024
4.3.2 By Type - Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales, 2025-2030
4.3.3 By Type - Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales Market Share, 2019-2030
4.4 By Type - Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Market Size, 2023 & 2030
5.1.2 Piglets
5.1.3 Adult Pigs
5.2 By Application - Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue & Forecasts
5.2.1 By Application - Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue, 2019-2024
5.2.2 By Application - Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue, 2025-2030
5.2.3 By Application - Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue Market Share, 2019-2030
5.3 By Application - Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales & Forecasts
5.3.1 By Application - Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales, 2019-2024
5.3.2 By Application - Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales, 2025-2030
5.3.3 By Application - Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales Market Share, 2019-2030
5.4 By Application - Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Market Size, 2023 & 2030
6.2 By Region - Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue & Forecasts
6.2.1 By Region - Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue, 2019-2024
6.2.2 By Region - Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue, 2025-2030
6.2.3 By Region - Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue Market Share, 2019-2030
6.3 By Region - Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales & Forecasts
6.3.1 By Region - Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales, 2019-2024
6.3.2 By Region - Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales, 2025-2030
6.3.3 By Region - Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue, 2019-2030
6.4.2 By Country - North America Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales, 2019-2030
6.4.3 US Inactivated Vaccine for Swine Mycoplasma Pneumonia Market Size, 2019-2030
6.4.4 Canada Inactivated Vaccine for Swine Mycoplasma Pneumonia Market Size, 2019-2030
6.4.5 Mexico Inactivated Vaccine for Swine Mycoplasma Pneumonia Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue, 2019-2030
6.5.2 By Country - Europe Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales, 2019-2030
6.5.3 Germany Inactivated Vaccine for Swine Mycoplasma Pneumonia Market Size, 2019-2030
6.5.4 France Inactivated Vaccine for Swine Mycoplasma Pneumonia Market Size, 2019-2030
6.5.5 U.K. Inactivated Vaccine for Swine Mycoplasma Pneumonia Market Size, 2019-2030
6.5.6 Italy Inactivated Vaccine for Swine Mycoplasma Pneumonia Market Size, 2019-2030
6.5.7 Russia Inactivated Vaccine for Swine Mycoplasma Pneumonia Market Size, 2019-2030
6.5.8 Nordic Countries Inactivated Vaccine for Swine Mycoplasma Pneumonia Market Size, 2019-2030
6.5.9 Benelux Inactivated Vaccine for Swine Mycoplasma Pneumonia Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue, 2019-2030
6.6.2 By Region - Asia Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales, 2019-2030
6.6.3 China Inactivated Vaccine for Swine Mycoplasma Pneumonia Market Size, 2019-2030
6.6.4 Japan Inactivated Vaccine for Swine Mycoplasma Pneumonia Market Size, 2019-2030
6.6.5 South Korea Inactivated Vaccine for Swine Mycoplasma Pneumonia Market Size, 2019-2030
6.6.6 Southeast Asia Inactivated Vaccine for Swine Mycoplasma Pneumonia Market Size, 2019-2030
6.6.7 India Inactivated Vaccine for Swine Mycoplasma Pneumonia Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue, 2019-2030
6.7.2 By Country - South America Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales, 2019-2030
6.7.3 Brazil Inactivated Vaccine for Swine Mycoplasma Pneumonia Market Size, 2019-2030
6.7.4 Argentina Inactivated Vaccine for Swine Mycoplasma Pneumonia Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales, 2019-2030
6.8.3 Turkey Inactivated Vaccine for Swine Mycoplasma Pneumonia Market Size, 2019-2030
6.8.4 Israel Inactivated Vaccine for Swine Mycoplasma Pneumonia Market Size, 2019-2030
6.8.5 Saudi Arabia Inactivated Vaccine for Swine Mycoplasma Pneumonia Market Size, 2019-2030
6.8.6 UAE Inactivated Vaccine for Swine Mycoplasma Pneumonia Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Zoetis
7.1.1 Zoetis Company Summary
7.1.2 Zoetis Business Overview
7.1.3 Zoetis Inactivated Vaccine for Swine Mycoplasma Pneumonia Major Product Offerings
7.1.4 Zoetis Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales and Revenue in Global (2019-2024)
7.1.5 Zoetis Key News & Latest Developments
7.2 Boehringer Ingelheim
7.2.1 Boehringer Ingelheim Company Summary
7.2.2 Boehringer Ingelheim Business Overview
7.2.3 Boehringer Ingelheim Inactivated Vaccine for Swine Mycoplasma Pneumonia Major Product Offerings
7.2.4 Boehringer Ingelheim Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales and Revenue in Global (2019-2024)
7.2.5 Boehringer Ingelheim Key News & Latest Developments
7.3 Jinhe Biotechnology
7.3.1 Jinhe Biotechnology Company Summary
7.3.2 Jinhe Biotechnology Business Overview
7.3.3 Jinhe Biotechnology Inactivated Vaccine for Swine Mycoplasma Pneumonia Major Product Offerings
7.3.4 Jinhe Biotechnology Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales and Revenue in Global (2019-2024)
7.3.5 Jinhe Biotechnology Key News & Latest Developments
7.4 Merck
7.4.1 Merck Company Summary
7.4.2 Merck Business Overview
7.4.3 Merck Inactivated Vaccine for Swine Mycoplasma Pneumonia Major Product Offerings
7.4.4 Merck Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales and Revenue in Global (2019-2024)
7.4.5 Merck Key News & Latest Developments
7.5 HIPRA
7.5.1 HIPRA Company Summary
7.5.2 HIPRA Business Overview
7.5.3 HIPRA Inactivated Vaccine for Swine Mycoplasma Pneumonia Major Product Offerings
7.5.4 HIPRA Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales and Revenue in Global (2019-2024)
7.5.5 HIPRA Key News & Latest Developments
7.6 Ceva Sant? Animale
7.6.1 Ceva Sant? Animale Company Summary
7.6.2 Ceva Sant? Animale Business Overview
7.6.3 Ceva Sant? Animale Inactivated Vaccine for Swine Mycoplasma Pneumonia Major Product Offerings
7.6.4 Ceva Sant? Animale Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales and Revenue in Global (2019-2024)
7.6.5 Ceva Sant? Animale Key News & Latest Developments
7.7 Harbin Pharmaceutical Group
7.7.1 Harbin Pharmaceutical Group Company Summary
7.7.2 Harbin Pharmaceutical Group Business Overview
7.7.3 Harbin Pharmaceutical Group Inactivated Vaccine for Swine Mycoplasma Pneumonia Major Product Offerings
7.7.4 Harbin Pharmaceutical Group Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales and Revenue in Global (2019-2024)
7.7.5 Harbin Pharmaceutical Group Key News & Latest Developments
7.8 Pulike Biotech
7.8.1 Pulike Biotech Company Summary
7.8.2 Pulike Biotech Business Overview
7.8.3 Pulike Biotech Inactivated Vaccine for Swine Mycoplasma Pneumonia Major Product Offerings
7.8.4 Pulike Biotech Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales and Revenue in Global (2019-2024)
7.8.5 Pulike Biotech Key News & Latest Developments
7.9 Qilu Animal Health Products
7.9.1 Qilu Animal Health Products Company Summary
7.9.2 Qilu Animal Health Products Business Overview
7.9.3 Qilu Animal Health Products Inactivated Vaccine for Swine Mycoplasma Pneumonia Major Product Offerings
7.9.4 Qilu Animal Health Products Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales and Revenue in Global (2019-2024)
7.9.5 Qilu Animal Health Products Key News & Latest Developments
7.10 Wuhan Keqian Biology
7.10.1 Wuhan Keqian Biology Company Summary
7.10.2 Wuhan Keqian Biology Business Overview
7.10.3 Wuhan Keqian Biology Inactivated Vaccine for Swine Mycoplasma Pneumonia Major Product Offerings
7.10.4 Wuhan Keqian Biology Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales and Revenue in Global (2019-2024)
7.10.5 Wuhan Keqian Biology Key News & Latest Developments
8 Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Capacity, Analysis
8.1 Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Capacity, 2019-2030
8.2 Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Capacity of Key Manufacturers in Global Market
8.3 Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Inactivated Vaccine for Swine Mycoplasma Pneumonia Supply Chain Analysis
10.1 Inactivated Vaccine for Swine Mycoplasma Pneumonia Industry Value Chain
10.2 Inactivated Vaccine for Swine Mycoplasma Pneumonia Upstream Market
10.3 Inactivated Vaccine for Swine Mycoplasma Pneumonia Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Inactivated Vaccine for Swine Mycoplasma Pneumonia Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Inactivated Vaccine for Swine Mycoplasma Pneumonia in Global Market
Table 2. Top Inactivated Vaccine for Swine Mycoplasma Pneumonia Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue Share by Companies, 2019-2024
Table 5. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales by Companies, (K Units), 2019-2024
Table 6. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Inactivated Vaccine for Swine Mycoplasma Pneumonia Price (2019-2024) & (US$/Unit)
Table 8. Global Manufacturers Inactivated Vaccine for Swine Mycoplasma Pneumonia Product Type
Table 9. List of Global Tier 1 Inactivated Vaccine for Swine Mycoplasma Pneumonia Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Inactivated Vaccine for Swine Mycoplasma Pneumonia Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales (K Units), 2019-2024
Table 15. By Type - Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales (K Units), 2025-2030
Table 16. By Application ? Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales (K Units), 2019-2024
Table 20. By Application - Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales (K Units), 2025-2030
Table 21. By Region ? Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales (K Units), 2019-2024
Table 25. By Region - Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales (K Units), 2025-2030
Table 26. By Country - North America Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales, (K Units), 2019-2024
Table 29. By Country - North America Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales, (K Units), 2025-2030
Table 30. By Country - Europe Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales, (K Units), 2019-2024
Table 33. By Country - Europe Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales, (K Units), 2025-2030
Table 34. By Region - Asia Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales, (K Units), 2019-2024
Table 37. By Region - Asia Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales, (K Units), 2025-2030
Table 38. By Country - South America Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales, (K Units), 2019-2024
Table 41. By Country - South America Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales, (K Units), 2025-2030
Table 46. Zoetis Company Summary
Table 47. Zoetis Inactivated Vaccine for Swine Mycoplasma Pneumonia Product Offerings
Table 48. Zoetis Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 49. Zoetis Key News & Latest Developments
Table 50. Boehringer Ingelheim Company Summary
Table 51. Boehringer Ingelheim Inactivated Vaccine for Swine Mycoplasma Pneumonia Product Offerings
Table 52. Boehringer Ingelheim Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 53. Boehringer Ingelheim Key News & Latest Developments
Table 54. Jinhe Biotechnology Company Summary
Table 55. Jinhe Biotechnology Inactivated Vaccine for Swine Mycoplasma Pneumonia Product Offerings
Table 56. Jinhe Biotechnology Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 57. Jinhe Biotechnology Key News & Latest Developments
Table 58. Merck Company Summary
Table 59. Merck Inactivated Vaccine for Swine Mycoplasma Pneumonia Product Offerings
Table 60. Merck Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 61. Merck Key News & Latest Developments
Table 62. HIPRA Company Summary
Table 63. HIPRA Inactivated Vaccine for Swine Mycoplasma Pneumonia Product Offerings
Table 64. HIPRA Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 65. HIPRA Key News & Latest Developments
Table 66. Ceva Sant? Animale Company Summary
Table 67. Ceva Sant? Animale Inactivated Vaccine for Swine Mycoplasma Pneumonia Product Offerings
Table 68. Ceva Sant? Animale Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 69. Ceva Sant? Animale Key News & Latest Developments
Table 70. Harbin Pharmaceutical Group Company Summary
Table 71. Harbin Pharmaceutical Group Inactivated Vaccine for Swine Mycoplasma Pneumonia Product Offerings
Table 72. Harbin Pharmaceutical Group Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 73. Harbin Pharmaceutical Group Key News & Latest Developments
Table 74. Pulike Biotech Company Summary
Table 75. Pulike Biotech Inactivated Vaccine for Swine Mycoplasma Pneumonia Product Offerings
Table 76. Pulike Biotech Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 77. Pulike Biotech Key News & Latest Developments
Table 78. Qilu Animal Health Products Company Summary
Table 79. Qilu Animal Health Products Inactivated Vaccine for Swine Mycoplasma Pneumonia Product Offerings
Table 80. Qilu Animal Health Products Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 81. Qilu Animal Health Products Key News & Latest Developments
Table 82. Wuhan Keqian Biology Company Summary
Table 83. Wuhan Keqian Biology Inactivated Vaccine for Swine Mycoplasma Pneumonia Product Offerings
Table 84. Wuhan Keqian Biology Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 85. Wuhan Keqian Biology Key News & Latest Developments
Table 86. Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2024 (K Units)
Table 87. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Capacity Market Share of Key Manufacturers, 2021-2024
Table 88. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Production by Region, 2019-2024 (K Units)
Table 89. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Production by Region, 2025-2030 (K Units)
Table 90. Inactivated Vaccine for Swine Mycoplasma Pneumonia Market Opportunities & Trends in Global Market
Table 91. Inactivated Vaccine for Swine Mycoplasma Pneumonia Market Drivers in Global Market
Table 92. Inactivated Vaccine for Swine Mycoplasma Pneumonia Market Restraints in Global Market
Table 93. Inactivated Vaccine for Swine Mycoplasma Pneumonia Raw Materials
Table 94. Inactivated Vaccine for Swine Mycoplasma Pneumonia Raw Materials Suppliers in Global Market
Table 95. Typical Inactivated Vaccine for Swine Mycoplasma Pneumonia Downstream
Table 96. Inactivated Vaccine for Swine Mycoplasma Pneumonia Downstream Clients in Global Market
Table 97. Inactivated Vaccine for Swine Mycoplasma Pneumonia Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Inactivated Vaccine for Swine Mycoplasma Pneumonia Segment by Type in 2023
Figure 2. Inactivated Vaccine for Swine Mycoplasma Pneumonia Segment by Application in 2023
Figure 3. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue, 2019-2030 (US$, Mn)
Figure 7. Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales in Global Market: 2019-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue in 2023
Figure 9. By Type - Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue Market Share, 2019-2030
Figure 11. By Type - Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales Market Share, 2019-2030
Figure 12. By Type - Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Price (US$/Unit), 2019-2030
Figure 13. By Application - Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue Market Share, 2019-2030
Figure 15. By Application - Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales Market Share, 2019-2030
Figure 16. By Application - Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Price (US$/Unit), 2019-2030
Figure 17. By Region - Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue Market Share, 2019-2030
Figure 20. By Region - Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales Market Share, 2019-2030
Figure 21. By Country - North America Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue Market Share, 2019-2030
Figure 22. By Country - North America Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales Market Share, 2019-2030
Figure 23. US Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales Market Share, 2019-2030
Figure 28. Germany Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue, (US$, Mn), 2019-2030
Figure 29. France Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales Market Share, 2019-2030
Figure 37. China Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue, (US$, Mn), 2019-2030
Figure 41. India Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue Market Share, 2019-2030
Figure 43. By Country - South America Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales Market Share, 2019-2030
Figure 44. Brazil Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales Market Share, 2019-2030
Figure 48. Turkey Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Inactivated Vaccine for Swine Mycoplasma Pneumonia Revenue, (US$, Mn), 2019-2030
Figure 52. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Capacity (K Units), 2019-2030
Figure 53. The Percentage of Production Inactivated Vaccine for Swine Mycoplasma Pneumonia by Region, 2023 VS 2030
Figure 54. Inactivated Vaccine for Swine Mycoplasma Pneumonia Industry Value Chain
Figure 55. Marketing Channels
